# Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food

> **NCT00419692** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 32 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Ropinirole

## Key facts

- **NCT ID:** NCT00419692
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08-24
- **Primary completion:** 2006-12-12
- **Final completion:** 2006-12-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00419692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00419692, "Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00419692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*